Botox®

The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke

Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines

Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity

A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy

A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Treatment of Moderate to Severe Glabellar Lines (BMI2006)

Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial

DWP450 for Treating Moderate to Severe Glabellar Lines

Double-blind Comparative Randomized Multicenter

BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity

Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis